Daugan; Alain Claude-Marie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Daugan; Alain Claude-Marie.The latest application filed is for "heterocyclic amides as kinase inhibitors".
Company Profile
4.20.24
- Daugan; Alain Claude-Marie - Les Ulis FR
- DAUGAN; Alain Claude-Marie - London GB
- Daugan, Alain Claude-Marie - Courtaboeuf FR
- Daugan; Alain Claude-Marie - Marly le Roi Cedex FR
Patent Activity
| Patent | Date |
|---|---|
| Heterocyclic Amides as Kinase Inhibitors App 20210253532 - Anderson; Niall Andrew ; et al. | 2021-08-19 |
| Heterocyclic amides as kinase inhibitors Grant 10,899,716 - Anderson , et al. January 26, 2 | 2021-01-26 |
| Heterocyclic Amides As Kinase Inhibitors App 20200165205 - ANDERSON; Niall Andrew ; et al. | 2020-05-28 |
| Heterocyclic amides as kinase inhibitors Grant 10,590,085 - Anderson , et al. | 2020-03-17 |
| Heterocyclic Amides As Kinase Inhibitors App 20190345138 - DAUGAN; Alain Claude-Marie ; et al. | 2019-11-14 |
| Chemical Compounds App 20180237441 - AXTEN; Jeffrey Michael ; et al. | 2018-08-23 |
| Heterocyclic Amides As Kinase Inhibitors App 20180134665 - ANDERSON; Niall Andrew ; et al. | 2018-05-17 |
| Quinolinone derivatives Grant 9,855,260 - Daugan , et al. January 2, 2 | 2018-01-02 |
| Quinolinone Derivatives App 20150238480 - DAUGAN; Alain Claude-Marie ; et al. | 2015-08-27 |
| Quinolinone derivatives Grant 9,061,998 - Daugan , et al. June 23, 2 | 2015-06-23 |
| Quinolinone Derivatives App 20130345212 - Daugan; Alain Claude-Marie ; et al. | 2013-12-26 |
| 1h-pyrollo[3,2-d]pyrimidinedione Derivatives App 20130345243 - Bouillot; Anne Marie Jeanne ; et al. | 2013-12-26 |
| Condensed Azepine Derivatives As Bromodomain Inhibitors App 20120202799 - Crowe; Miriam ; et al. | 2012-08-09 |
| Thiadiazole Derivatives, Inhibitors Of Stearoyl-coa Desaturase App 20100120669 - Bouillot; Anne Marie Jeanne ; et al. | 2010-05-13 |
| Compounds App 20100048617 - Daugan; Alain Claude-Marie | 2010-02-25 |
| Compounds App 20100041696 - Daugan; Alain Claude-Marie ; et al. | 2010-02-18 |
| Compounds App 20100022486 - Bouillot; Anne Marie Jeanne ; et al. | 2010-01-28 |
| Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction Grant 6,962,918 - Orme , et al. November 8, 2 | 2005-11-08 |
| Pyrazino[1',2':1,6]pyrido[3,4b]indole derivatives Grant 6,911,542 - Orme , et al. June 28, 2 | 2005-06-28 |
| Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1',2':1,6]pyrido[3,4b]-indole-1,4-dione Grant 6,872,721 - Orme , et al. March 29, 2 | 2005-03-29 |
| Condensed pyridoindole derivatives Grant 6,858,620 - Orme , et al. February 22, 2 | 2005-02-22 |
| Condensed pyridoindole derivatives Grant 6,838,456 - Orme , et al. January 4, 2 | 2005-01-04 |
| Tetracyclic derivatives, process of preparation and use Grant 6,784,179 - Daugan August 31, 2 | 2004-08-31 |
| Chemical compounds App 20040082787 - Orme, Mark W ; et al. | 2004-04-29 |
| Use of therapeutic benzamide derivatives App 20040044008 - Daugan, Alain Claude-Marie ; et al. | 2004-03-04 |
| Benzamide derivatives and their use as apob-100 and mtp inhibitors App 20040024215 - Daugan, Alain Claude - Marie ; et al. | 2004-02-05 |
| Chemical compounds App 20030236263 - Orme, Mark W. ; et al. | 2003-12-25 |
| Chemical compounds App 20030225092 - Orme, Mark W. ; et al. | 2003-12-04 |
| Chemical compounds App 20030225094 - Orme, Mark W ; et al. | 2003-12-04 |
| Chemical compounds App 20030207906 - Orme, Mark W. ; et al. | 2003-11-06 |
| Use of cGMP phosphodiesterase inhibitors in methods to treat female sexual dysfunction Grant 6,608,065 - Daugan August 19, 2 | 2003-08-19 |
| Tetracyclic diketopiperazine compounds as pdev inhibitors App 20030153575 - Orme, Mark W. ; et al. | 2003-08-14 |
| Benzamide derivatives and their use as ApoB-100 secretion inhibitors Grant 6,552,022 - Daugan April 22, 2 | 2003-04-22 |
| Tetracyclic derivatives, process of preparation and use App 20020119976 - Daugan, Alain Claude-Marie | 2002-08-29 |
| Treatment method using a cGMP-Specific PDE inhibitor Grant 6,218,400 - Daugan , et al. April 17, 2 | 2001-04-17 |
| Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use Grant 6,143,746 - Daugan , et al. November 7, 2 | 2000-11-07 |
| Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence Grant 6,140,329 - Daugan October 31, 2 | 2000-10-31 |
| Chemical compounds Grant 6,001,847 - Daugan , et al. December 14, 1 | 1999-12-14 |
| Cyclic GMP-specific phosphodiesterase inhibitors Grant 5,981,527 - Daugan , et al. November 9, 1 | 1999-11-09 |
| Tetracyclic derivatives; process of preparation and use Grant 5,859,006 - Daugan January 12, 1 | 1999-01-12 |
| Certain isoquinoline derivatives having anti-tumor properties Grant 5,663,179 - Dumaitre , et al. September 2, 1 | 1997-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 